Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs extended-release tacrolimus monotherapy after Campath 1-H induction in kidney transplantation
2008-000889-22Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Oct 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tacrolimus in kidney allograft rejection (2 arms), sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Survival with a functioning graft at 1 year and Survival with a functioning graft at 3 years. Started Oct 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2008-000889-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000889-22.